The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Yoshinobu Onuma

Showing 1-20 of 176 articles
A Comparison of Risk Prediction Models for Patients with Acute Coronary Syndromes
Hara H, O'Leary N, Ono M, Onuma Y, Serruys P
August 17, 2021 | 10.4244/EIJ-D-21-00536
Interventions for valvular disease
Chronic Hemodynamic Performance of a Biorestorative Transcatheter Heart Valve in an Ovine Model
Serruys P, Kawashima H, Chang C, Modolo R, Wang R, de Winter R, Van Hauwermeiren H, El-Kurdi M, van den Bergh W, Cox M, Onuma Y, Flameng W, Soliman O
July 20, 2021 | 10.4244/EIJ-D-21-00386
Coronary interventions
Optimal Dual Antiplatelet Therapy Duration for Bioresorbable Scaffolds: an Individual Patient Data Pooled Analysis of the ABSORB Trials
Azzalini L, Ellis SG, Kereiakes D, Kimura T, Gao R, Onuma Y, Chevalier B, Dressler O, Crowley A, Zhou Z, Redfors B, Serruys P, Stone G
June 8, 2021 | 10.4244/EIJ-D-21-00263
Impact of the CABG SYNTAX score on all-cause death at 10 years: a SYNTAX Extended Survival (SYNTAXES) substudy
Takahashi K, Thuijs D, Hara H, Wang R, Mohr F, Morice M, Holmes D, Kappetein A, Head S, Onuma Y, Serruys P
May 16, 2021 | 10.4244/EIJ-D-20-00170
Statistical methods for composite endpoints
Hara H, van Klaveren D, Kogame N, Chichareon P, Modolo R, Tomaniak M, Ono M, Kawashima H, Takahashi K, Capodanno D, Onuma Y, Serruys P
April 2, 2021 | 10.4244/EIJ-D-19-00953
Online three-dimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions: design and rationale of the randomised OPTIMUM trial
Miyazaki Y, Muramatsu T, Asano T, Katagiri Y, Sotomi Y, Nakatani S, Takahashi K, Kogame N, Higuchi Y, Ishikawa M, Kyono H, Yano M, Ozaki Y, Serruys P, Okamura T, Onuma Y
March 19, 2021 | 10.4244/EIJ-D-18-00902
Coronary interventions
Age and Functional Relevance of Coronary Stenosis: a Post-Hoc Analysis of the ADVISE II Trial
Faria DC, Lee J, van der Hoef T, Mejía-Rentería H, Echavarría-Pinto M, Baptista SB, Cerrato E, García-García H, Davies J, Onuma Y, Samady H, Piek J, Serruys P, Lerman A, Escaned J
March 16, 2021 | 10.4244/EIJ-D-20-01163
Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study
Milewski K, Takahashi K, Asano T, Katagiri Y, Hochul M, Buszman P, Tomaniak M, Gorycki B, Zurakowski A, Janas A, Mlodziankowski A, Kachel M, Wykrzykowska J, Wijns W, de Winter R, Buszman P, Onuma Y, Serruys P
February 19, 2021 | 10.4244/EIJ-D-18-01201
Coronary interventions in 2020: the year in review
Lunardi M, Gao C, Hara H, Ono M, Kawashima H, Wang R, Wijns W, Serruys P, Onuma Y
February 5, 2021 | 10.4244/EIJ-D-20-01343
A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trial
Hara H, Gao C, Kogame N, Ono M, Kawashima H, Wang R, Morel M, O'Leary N, Sharif F, Möllmann H, Reiber J, Sabaté M, Zaman A, Wijns W, Onuma Y, Serruys P
December 18, 2020 | 10.4244/EIJ-D-20-00772
BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial
Chang C, Kogame N, Asano T, von Birgelen C, Sabaté M, Onuma Y, Serruys P
December 4, 2020 | 10.4244/EIJ-D-19-00566
Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
Onuma Y, Chevalier B, Ono M, Cequier A, Dudek D, Haude M, Carrié D, Sabaté M, Windecker S, Rapoza R, West N, Reith S, de Sousa Almeida M, Campo G, Iniguez-Romo A, Serruys P
December 4, 2020 | 10.4244/EIJ-D-20-00024
Valvular heart interventions: advances from 2019 to 2020
Wang R, Gao C, Kawashima H, Modolo R, Rosseel L, Onuma Y, Soliman O, Serruys P, Mylotte D
November 20, 2020 | 10.4244/EIJ-D-20-00096
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K, Chichareon P, Modolo R, Kogame N, Chang C, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen J, Wykrzykowska J, de Winter R, Hamm C, Steg P, Stoll H, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys P
October 23, 2020 | 10.4244/EIJ-D-19-00498
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial
Smits P, Chang C, Chevalier B, West N, Gori T, Barbato E, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Wlodarczak A, Abdel-Wahab M, Esposito G, Tijssen J, Morice M, Onuma Y, van Geuns R
October 23, 2020 | 10.4244/EIJ-D-19-01079
Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study
Asano T, Kogame N, Onuma Y, Modolo R, Chichareon P, Lefèvre T, Legutko J, Digne F, Morel M, Serruys P, Gil R
October 23, 2020 | 10.4244/EIJ-D-19-00361
Quantitative aortography assessment of aortic regurgitation
Modolo R, Chang C, Onuma Y, Schultz C, Tateishi H, Abdelghani M, Miyazaki Y, Aben J, Rutten M, Pighi M, El Bouziani A, van Mourik M, Lemos P, Wykrzykowska J, Brito F, Sahyoun C, Piazza N, Eltchaninoff H, Soliman O, Abdel-Wahab M, Van Mieghem N, de Winter R, Serruys P
October 9, 2020 | 10.4244/EIJ-D-19-00879
Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication.
Katagiri Y, Torii R, Takahashi K, Tenekecioglu E, Asano T, Chichareon P, Tomaniak M, Piek J, Wykrzykowska J, Bullett N, Ahmed N, Al-Lamee K, Al-Lamee R, Leclerc G, Kitslaar P, Dijkstra J, Reiber J, Poon E, Bourantas C, Gijsen F, Serruys P, Onuma Y
June 12, 2020 | 10.4244/EIJ-D-18-01190
The SYNTAX score on its way out or … towards artificial intelligence: part I
Serruys P, Chichareon P, Modolo R, Leaman D, Reiber J, Emanuelsson H, Di Mario C, Pijls N, Morel M, Valgimigli M, Farooq V, van Klaveren D, Capodanno D, Andreini D, Bourantas C, Davies J, Banning A, Escaned J, Piek J, Echavarría-Pinto M, Taylor C, Thomsen B, Collet C, Pompilio G, Bartorelli A, Glocker B, Dressler O, Stone G, Onuma Y
May 20, 2020 | 10.4244/EIJ-D-19-00543A
The SYNTAX score on its way out or … towards artificial intelligence: part II
Serruys P, Chichareon P, Modolo R, Leaman D, Reiber J, Emanuelsson H, Di Mario C, Pijls N, Morel M, Valgimigli M, Farooq V, van Klaveren D, Capodanno D, Andreini D, Bourantas C, Davies J, Banning A, Escaned J, Piek J, Echavarría-Pinto M, Taylor C, Thomsen B, Collet C, Pompilio G, Bartorelli A, Glocker B, Dressler O, Stone G, Onuma Y
May 20, 2020 | 10.4244/EIJ-D-19-00543B

Latest news

NEW ISSUE
Robotics, AI and Imaging State of The Art; Bleeding Risk and Mortality in CAD; Treating Refractory Angina by Coronary Sinus Narrowing; and more
September 20, 2021
STATE OF THE ART
Robotics, imaging, and artificial intelligence in the catheterisation laboratory
Rafael Beyar et al.
September 20, 2021
AHEAD OF PRINT
ViV TAVI vs repeat SAVR
Monil Majmundar et al.
September 15, 2021
AHEAD OF PRINT
Thrombectomy for ischaemic stroke
Christopher A. Rajkumar et al.
September 10, 2021
EDITORIAL
Walking the tightrope between ischaemia and bleeding
Michelle L. O’Donoghue et al.
September 20, 2021
EDITORIAL
Microvascular dysfunction endotypes and outcomes
Christos V. Bourantas et al.
September 20, 2021
EDITORIAL
Coronary sinus reducer therapy for refractory angina: is it ready for prime time?
Michael Foley et al.
September 20, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke